The English text is an unofficial
translation. In case of any discrepancies between the Swedish text
and the English translation, the Swedish text shall
prevail.
Press release
Lund on 1 December 2016
NOTICE OF EXTRAORDINARY
SHAREHOLDERS' MEETING IN ENZYMATICA AB (publ)
The shareholders in Enzymatica AB
(publ), reg. no 556719-9244 (the "Company") are hereby invited to
attend the extraordinary shareholders' meeting to be held on
Monday, 19 December 2016 at 2 p.m. at Elite Hotel Ideon,
Scheelevägen 27 in Lund.
Right to participate and
notice
Only shareholders that are recorded in their own name in the
Company's share ledger kept by Euroclear Sweden AB (The Swedish
Central Securities Depository Euroclear Sweden AB) on
13 December 2016, and also have given notice as per the same
date to the Company of their intent to participate, preferably no
later than 4.00 p.m., have the right to participate in the
shareholders' meeting. A shareholder may be accompanied by not more
than two advisors, provided that the number of such advisors has
been notified to the Company no later than the aforementioned time.
Proxies need not notify the number of advisors in advance.
Notice shall be given in writing to Enzymatica AB
(publ), att: bolagsstämma, Ideon Science Park, 223 70 Lund or
by e-mail to louise.forsell@enzymatica.com. The notice should
specify the shareholder's name, personal identity or company
registration number, address, work-hour telephone number and
shareholding, and names of any advisors.
Trustee-registered
shares
In order to be entitled to participate in the meeting, shareholders
whose shares are trustee-registered must temporarily register their
shares in their own names. Such registration should be requested
from the trustee, and must be executed with Euroclear Sweden AB not
later than on 13 December 2016. Shareholders that wish to execute
such registration must, well in advance before the said date,
notify its trustee thereof.
Proxies
If a shareholder intends to participate by proxy, the proxy must
bring a written and dated proxy signed by the shareholder in
original to the meeting. The proxy may not be older than five
years. Proxy forms can be downloaded from the Company's website,
www.enzymatica.com. If the proxy is issued by a legal entity, the
proxy must also bring current registration certificate (Sw.
registreringsbevis) of the legal entity or
similar document of authorisation for the legal entity.
In order to facilitate registration, proxies and
authorization documents should be the Company to hand at the
above-mentioned address well in advance before the meeting.
Proposed agenda
1. Opening of the
meeting
2. Election of chairman
of the meeting
3. Preparation and
approval of the register of voters
4. Approval of the
agenda
5. Election of one or
two persons to confirm the minutes
6. Determination as to
whether the meeting has been duly convened
7.
(a)
Determination of number of members of the board of
directors
(b) Dismissal
and election of members of the board of directors
(c)
Election of chairman of the board of directors
(d)
Determination of remuneration to members of the board of
directors
8. Closing of the
meeting
Resolution proposals - item
7
Shareholders representing more than 50 percent of
the total number of shares and votes in the Company have proposed
that the shareholders' meeting shall resolve:
(a)
that the board of directors shall consist of six (6) ordinary board
members with no deputy members;
(b)
that the current ordinary board members Lennart Nilsson, Hans Pihl,
Nils Siegbahn and Monica Wallter are dismissed (Sw. entledigade) and that Bengt Baron, Mats K Andersson
and Louise Nicolin are elected as new ordinary board members for
the period until the next annual general meeting. Marianne Dicander
Alexandersson, Gudmundur Palmason and Sigurgeir Gudlaugsson shall
remain as ordinary board members;
(c)
that Bengt Baron is elected chairman of the board of directors;
and
(d)
that remuneration to newly elected ordinary board members shall be
paid in the same amounts (pro rata) as
resolved for the chairman of the board of directors and the
ordinary board members by the annual general meeting 2016, i.e. SEK
180,000 for the chairman and SEK 120,000 to every other member of
the board of directors (on annual basis).
The reason for the proposal is that Lennart
Nilsson wish to resign as member of the board and that shareholders
have expressed a desire to simultaneously appoint a board of
directors that better represent the new shareholder structure in
the Company.
Information regarding ordinary
board members proposed for new election
Bengt Baron
Born 1962. BSc in Business Administration and MBA from University
of California, Berkeley. Bengt currently has appointments as
chairman of the board in MIPS AB and as board member in Thule Group
AB (publ) and 5653 Sweden AB. Bengt has previously been CEO at
Cloetta AB and Leaf International B.V. Bengt holds no shares in the
Company.
Mats K Andersson
Born 1955. Education in International Economics from Lund
University. Courses from Stockholm School of Economics Executive
Education and Insead. Mats currently has appointments as chairman
of the board in Lomond Invest AB, Abanico Invest AB and Andersson
& Co AB, and as board member in Volati Parts AB and Golf Hills
AB. Mats has previously been CEO at Lomond Industrier AB and
Business Unit Manager and deputy CEO at LICare AB (publ). Mats
holds 11,346,951 shares in the Company (directly and indirectly
through company).
Louise Nicolin
Born 1973. MSc in Molecular Biotechnology from Uppsala University.
Exc. MBA from Stockholm School of Business. Louise currently has
appointments as chairman of the board in Better Business World Wide
and as board member in Volati AB (publ), VBG Group AB (publ),
Uppdragshuset Sverige AB and board assignments within Dellner
Couplers AB. Louise is since year 2000 running a consultant
business at Nicolin Consulting AB with focus on business
development and quality assurance, and has previously been Business
Unit Manager and Consultant Manager at PlantVision AB. Louise holds
no shares in the Company.
Total number of shares and votes
The total number of shares and votes in the Company amounts as per
the date of this notice to 90,887,808. The Company holds no
shares.
The shareholders are reminded of their right to
request information from the board of directors and the CEO at the
meeting in accordance with Chap. 7 Sec. 32 of the Swedish Companies
Act (Sw. Aktiebolagslagen (2005:551)).
Meeting documents
This notice contains the complete proposal, which is also available
for the shareholders at the Company's website and at the Company at
its above mentioned address and will be sent free of charge to the
shareholders upon their request to the Company, provided that such
shareholders state their current address.
Lund in December 2016
The board of directors
For
more information, please contact:
Lennart Nilsson, Styrelseordförande Enzymatica
AB
Tel: 0705-12 32 95 | E-post: lennart.nilsson@crafoord.se
About Enzymatica AB
Enzymatica is a life science company who develops and sells medical
device products against infectious-related diseases. Over a short
period the company has developed a unique oral spray for colds,
ColdZyme®, and launched it on six markets. The product has become
one of the leading articles for colds in Swedish pharmacies.
Enzymatica's strategy is to continue growing by strengthening its
position in existing markets and to expand to more geographical
markets through well-established partners. The company is
headquartered in Lund, Sweden and is listed on Nasdaq First North.
For more information, please visit www.enzymatica.com.
Enzymatica's Certified Advisor is Erik Penser
Bankaktiebolag.
Enzymatica AB - Notice EGM
2016-12-19
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Enzymatica AB via Globenewswire
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jun 2024 to Jul 2024
ENZYMOTEC LTD. (NASDAQ:ENZY)
Historical Stock Chart
From Jul 2023 to Jul 2024